The pharma royalty funding market hit a record $10 billion in 2025. A single AI experiment that improved a cancer drug in ...

Chiesi Group (“Chiesi”), an international research-focused biopharmaceutical group and certified B Corp, and KalVista ...

Chiesi Group is taking KalVista Pharmaceuticals under its wing, paying $1.9 billion for the biotech’s oral therapy Ekterly to ...

Italy's family-owned Chiesi Group will buy U.S.-listed KalVista Pharmaceuticals ​in an all-cash deal valued at about $1.9 ...

Nasus Pharma Ltd., a clinical-stage specialty pharmaceutical company focused on the development of intranasal drugs to treat emergency medical conditions. It offers Powder-Based Intranasal (PBI) ...

Indian equities faced one of the sharper corrections in recent memory, with the S&P BSE 500 TRI plunging nearly 11.4% in ...

ETRetail.com brings latest hindustan unilever ltd news, views and updates from all top sources for the Indian Retail industry.

Sun Pharmaceutical Industries is preparing to raise a multibillion debt financing backing a potential bid for US healthcare company Organon & Co in what could become the largest overseas acquisition ...

Vertex Pharmaceuticals' business will suffer if other drugmakers launch competing cystic fibrosis drugs. Despite this threat, Vertex Pharmaceuticals' core franchise looks safe for the foreseeable ...

Mazagon Dock Shipbuilders and GAIL are among eight stocks that may be downgraded to the midcap category, while Vodafone Idea, currently a midcap, could be upgraded to the largecap segment in AMFI’s ...

GSK, a biopharmaceutical company, has withdrawn its application to the FDA for leucovorin calcium tablets, months after the White House promoted the drug as a potential treatment for autism-related ...

An enforcement report by the U.S. Food and Drug Administration has prompted a recall of more than 3 million bottles of eye drops from a California pharmaceutical company over concerns the products may ...